Cited by 507Mesenchymal stem cell researchHematopoietic Stem Cell TransplantationPluripotent Stem Cells Research

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Open access
Ghannam, Soufiane, Bouffi, Carine, Djouad, Farida, Jorgensen, Christian, Noël, Danièle·2010·Stem Cell Research & Therapy

Abstract

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitor cells that are isolated from many adult tissues, in particular from the bone marrow and adipose tissue. Along with their capacity for differentiating into cells of mesodermal lineage, such as adipocytes, osteoblasts and chondrocytes, these cells have also generated great interest for their ability to display immunomodulatory capacities. Indeed, a major breakthrough came with the finding that they are able to induce peripheral tolerance, suggesting they may be used as therapeutic tools in immune-mediated disorders. The present review aims at discussing the current knowledge on the targets and mechanisms of MSC-mediated immunosuppression as well as the potential use of MSCs as modulators of immune responses in a variety of diseases related to alloreactive immunity or autoimmunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/scrt2

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A prerequisite for the immunomodulatory function of mesenchymal stromal cells in the tumour microenvironment is their activation by immune cells producing IFN-γ, TNF-a, IL-2a or IL-1b.

    “A prerequisite for the immunomodulatory function of MSCs in the tumour microenvironment is their activation by immune cells producing IFN-γ, TNF-a, IL-2a or IL-1b [34], [35], [36].”

    From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [36]

    The section “Immunosuppressive function of mesenchymal stem cells requires preliminary activation” says immune-cell cytokines activate MSCs before immunosuppression. It lists IFNγ, alone or with TNFα, IL-1α, or IL-1β—not IL-2α—and does not establish this prerequisite specifically in the tumour microenvironment. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D.
Affiliations
Inserm (FR)
Corresponding author
Noël, Danièle
Venue
Stem Cell Research & Therapy
Published
2010-03
Volume
1
Issue
1
Pages
2-2
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2161905225
Cited by
507
References
68
Citations by year
2026: 4 · 2025: 10 · 2024: 24 · 2023: 24 · 2022: 26 · 2021: 35 · 2020: 36 · 2019: 31 · 2018: 32 · 2017: 33 · 2016: 41 · 2015: 46 · 2014: 46 · 2013: 44 · 2012: 36
FWCI
16.80
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research & Therapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Agence Nationale de la Recherche
  • Institut National de la Santé et de la Recherche Médicale
  • Université de Montpellier
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
mesenchymal stem cells, immunosuppression, immunomodulation, peripheral tolerance, autoimmunity, immune-mediated diseases, bone marrow-derived stem cells, adipose-derived stem cells, mesoderm differentiation
MeSH terms
Animals, Autoimmune Diseases, Dendritic Cells, Graft vs Host Disease, Humans, Immunosuppression Therapy, Neutrophils, Transplantation Immunology, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Mesenchymal Stem Cell Transplantation, Mice, Mesenchymal Stem Cells, Peripheral Tolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review